Breast cancer in young women and prognosis: How important are proliferation markers?
Hanna Fredholm1,2, Kristina Magnusson3, Linda S. Lindström4, Nicholas P. Tobin5, Henrik Lindman6, Jonas Bergh5,7, Lars Holmberg8,9, Fredrik Pontén3, Jan Frisell1,2, Irma Fredriksson1,2
1Karolinska Institutet, Department of Molecular Medicine and Surgery, Stockholm, Sweden
2Department of Breast- and Endocrine Surgery, Karolinska University Hospital, Stockholm, Sweden
3Uppsala University, Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala, Sweden
4Karolinska Institutet, Department of Biosciences and Nutrition, Stockholm, Sweden
5Karolinska Institutet, Department of Oncology and Pathology, Cancer Center Karolinska, Stockholm, Sweden
6Uppsala University, Department of Radiology, Oncology and Radiation Science, Uppsala University Hospital, Uppsala, Sweden
7Karolinska Oncology, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden
8Uppsala University, Department of Surgical Sciences, Regional Cancer Center, Uppsala University Hospital, Uppsala, Sweden
9King's College London, Faculty of Life Sciences and Medicine, Division of Cancer Studies, London, UK
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
European Journal of Cancer
Tập 84
278-289
Thông tin tác giả